NasdaqGS:DXCMMedical Equipment
Is DexCom (DXCM) Fully Valued Following Strong Earnings And Higher Revenue Guidance?
DexCom (DXCM) is back in focus after its latest quarterly update, which combined higher second quarter revenue and net income with a raised full year sales outlook and confirmation of a completed share repurchase program.
See our latest analysis for DexCom.
The latest earnings release and higher full year revenue guidance have coincided with a strong upswing in DexCom's share price, including a 57.04% 90 day share price return and 36.46% year to date share price return, while the 3 year total...